Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the long-term safety and tolerability of open-label treatment with Sandostatin LAR 30 mg in patients who completed the double-masked study CSMS995 0802
Critère d'inclusion
- Moderately severe or severe non-proliferative diabetic retinopathy (NPDR) or low risk proliferative diabetic retinopathy (PDR)